Which Form of Tenofovir Should Be Used Worldwide: Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide?
- PMID: 38606797
- DOI: 10.1093/cid/ciae190
Which Form of Tenofovir Should Be Used Worldwide: Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide?
Keywords: HIV; clinical obesity; dolutegravir; tenofovir alafenamide; tenofovir disoproxil fumarate.
Conflict of interest statement
Potential conflicts of interest. The author: No reported conflicts of interest. The author has submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Comment on
-
Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide in People With HIV.Clin Infect Dis. 2024 Oct 15;79(4):990-998. doi: 10.1093/cid/ciae189. Clin Infect Dis. 2024. PMID: 38606792 Free PMC article.
-
Antiretrovirals and Weight Change: Weighing the Evidence.Clin Infect Dis. 2024 Oct 15;79(4):999-1005. doi: 10.1093/cid/ciae191. Clin Infect Dis. 2024. PMID: 38606799 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical